Abstract
This paper focuses on the risk of unknown and uncertain long-term effects of stem cell research and its applications. Research on human embryonic stem cells and induced pluripotent stem cells are used as examples. We discuss some problems that such uncertain knowledge creates for decision makers, and describe how difficult decision making in this context really is. A method for handling this type of hard choice situations is presented and discussed.
The authors wish to thank Anders Castor, Göran Hermerén, Mattias Höglund and Jan Wahlström for constructive comments and help.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Of course, uncertainties emerge from the fact that the fibroblasts are grown in vitro; ordinary cells live under completely different environmental pressures.
- 2.
Those of us looking at this research area from without wonder why tailor-made differentiated cells are not the best alternative if we wish to avoid uncertainties, i.e., by way, not of inducing uncertainty, but blocking combinatorial possibilities. A multipotent, non-pluripotent, cell does not go off the rails as easily.
References
Brännmark J, Sahlin, N-E. Ethical theory and philosophy of risk: First thoughts. Journal of Risk Research 2008; 11:237–54.
Belmonte JCI, Ellis J, Hochedlinger K, Yamanaka S. Viewpoint: Induced pluripotent stem cells and reprogramming: Seeing the science through the hype. Nature 2009; 10:878–83.
Induced Pluripotent Stem Cells, Wikipedia.
Castor A. Stem and progenitor cell involvement in acute lymphoblastic leukemia. Lund University, Faculty of Medicine doctoral dissertation series, Lund 2007: 59.
Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315–22.
Doi A, Park IH, Wen B, Murakami P, Aryee MJ, Irizarry R et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human-induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nature Genetics 2009; 41:1350–4.
Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5:111–23.
Movassagh M, Choy M-K, Goddard M, Bennett MR, Down TA, et al. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One 2010; 5:e8564. doi: 10.1371.
Sahlin N-E, Persson J. Epistemic risk: The significance of knowing what one does not know. In: Brehmer, B, Sahlin, N-E (Eds). Future risks and risk management. Dordrecht: Kluwer. 1994, pp. 37–62.
Kahneman D, Wakker, P, Sarin, R. Back to Bentham: Explorations of experienced utility. The Quarterly Journal of Economics 1997; 112:375–405.
Frederick S, Loewenstein G. Hedonic adaptation. In: Kahneman D, et al. (Eds). Well-being: The foundations of hedonic psychology. New York: Russell Sage Foundation. 1999: pp. 302–29.
Tyc V. Psychological adaptation of children and adolescents with limb deficiencies: A review. Clinical Psychological Review 1992; 2:275–91.
Vareman N, Persson J. Why separate risk assessors and risk managers? Further external values affecting the risk assessor qua risk assessor. Journal of Risk Research 2010; 13:687–700.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sahlin, NE., Persson, J., Vareman, N. (2011). Unruhe und Ungewissheit: Stem Cells and Risks. In: Hug, K., Hermerén, G. (eds) Translational Stem Cell Research. Stem Cell Biology and Regenerative Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-959-8_30
Download citation
DOI: https://doi.org/10.1007/978-1-60761-959-8_30
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-958-1
Online ISBN: 978-1-60761-959-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)